Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.

Nutrition and cancer - 1 Jan 2006

Goodman Michael, Bostick Roberd M, Ward Kevin C, Terry Paul D, van Gils Carla H, Taylor Jack A, Mandel Jack S

Abstract excerpt

Lycopene has been associated with reduced prostate cancer risk, although the results of epidemiological studies have varied. We hypothesize that an effect of lycopene may be modified by XRCC1 genotype and other antioxidants. We used a food-frequency questionnaire to assess lycopene intake in a ca...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Carotene
Share to alpha-Tocopherol
Share to Anticarcinogenic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carotenoids

Share to Confidence Intervals

Share to Lycopene

Share to North Carolina

Share to X-ray Repair Cross Complementing Protein 1

Source

Identifiers

PMID: 16965236
DOI: 10.1207/s15327914nc5501_2

Genes

XRCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16965236-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.PMID 16965236Read ↗

An appraisal of the therapeutic value of lycopene for the chemoprevention of prostate cancer: A nutrigenomic approachSemantic proximity Read ↗

Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study.Semantic proximity Read ↗

Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene.Semantic proximity Read ↗

Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.Semantic proximity Read ↗

Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.Semantic proximity Read ↗

Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.Semantic proximity Read ↗

Gene Expression and Biological Pathways in Tissue of Men with Prostate Cancer in a Randomized Clinical Trial of Lycopene and Fish Oil SupplementationSemantic proximity Read ↗

Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.Semantic proximity Read ↗

Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.Semantic proximity Read ↗

A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer.Semantic proximity Read ↗

Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk.Semantic proximity Read ↗

Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.